Andere talen Immuron Limited

Aandelen

Beurs gesloten - Australian S.E. Andere beurzen 07:40:01 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,1 ^AUD	0,00%		0,00%	+29,87%

10/04	Wereldwijde omzet Immuron stijgt met 51% in maart; aandelen stijgen met 18%	MT
07/03	Sectorupdate: Gezondheidszorgaandelen stijgen aan het eind van de middag	MT

Immuron to host Live Virtual Event	15/04
Immuron Travelan® sales continued strong growth	10/04
Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	10/04
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10/04
Sector Update: Health Care Stocks Gain Late Afternoon	07/03
Sector Update: Health Care	07/03
Top Midday Gainers	07/03
Top Premarket Gainers	07/03
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07/03
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	07/03
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	07/03
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Immuron Presentation Australian Biologics Festival 2024	21/02
Immuron Presentation Australian Biologics Festival 2024	21/02
Immuron achieves record Travelan® sales	13/02
Immuron achieves record Travelan® sales	13/02
Immuron Limited Reports Unaudited Net Sales Results for the Year to Date Ended January 2024	13/02
Immuron's Travelan Immune Supplement Registers AU$2.7 Million Sales in YTD January	13/02
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	08/02
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	08/02

Geen resultaten voor deze zoekopdracht